CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
Ortho-Novum 777drug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000420
NCT00000420Phase 3Completed
CompareCT.gov

Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA): Oral Contraceptives

NYU Langone Health·interventional·Posted Nov 4, 1999·Updated May 3, 2013

In Brief

A Phase 3 clinical trial evaluating Ortho-Novum 777 for Systemic Lupus Erythematosus. Completed, across 15 sites.

Detailed Summary

Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA) is a study to test whether women with systemic lupus erythematosus (SLE or lupus) can safely use estrogen. We will determine this by looking at the effects of oral contraceptives (birth control pills, also known as "the pill") on disease activity and severity in women with SLE. The results of the study will show whether it is safe for women with SLE to use the pill.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSystemic Lupus Erythematosus
CountriesUnited States
CollaboratorsNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Office of Research on Women's Health (ORWH)

Timeline

Phase 3CompletedFinished
1997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 4, 1999
Enrollment StartJun 1, 1997
Study CompletionAug 1, 2003
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

Ortho-Novum 777drug